Rifat Pamukcu Aprea Therapeutics, Inc. (APRE) insider trading activity
Rifat Pamukcu is Director of Aprea Therapeutics, Inc.. Currently has a direct ownership of 4,401 shares of APRE, which is worth approximately $16,811. The most recent transaction as insider was on Jun 20, 2024, when has been sold 1,045 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
4.4K
31.14%
3M change
92.3%
12M change
Total Value Held
$16,811
Rifat Pamukcu Transaction History
RP
Rifat Pamukcu
Director
Boston, MA